Skip to main navigation Skip to search Skip to main content

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

  • Clement K. Chan
  • , Wesley T. Beaulieu
  • , Brandon J. Lujan
  • , Maziar Lalezary
  • , Daniella Lent-Schochet
  • , Therlinder Lo
  • , Glenn Yiu

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number1
JournalTranslational Vision Science and Technology
Volume12
Issue number9
DOIs
StatePublished - Sep 1 2023

ASJC Scopus Subject Areas

  • Biomedical Engineering
  • Ophthalmology

Keywords

  • exudative age-related macular degeneration
  • geographic atrophy (GA)
  • intermediate age-related macular degeneration
  • macular thickness
  • neovascular age-related macular degeneration (nAMD)
  • nonexudative age-related macular degeneration
  • Vascular Endothelial Growth Factor A
  • Geographic Atrophy
  • Prospective Studies
  • Humans
  • Child, Preschool
  • Wet Macular Degeneration/diagnosis
  • Visual Acuity
  • Angiogenesis Inhibitors/therapeutic use
  • Ranibizumab/therapeutic use
  • Retina/diagnostic imaging

Cite this